Source: Naunyn-Schmiedeberg's Archives of Pharmacology. Unidade: FMRP
Subjects: FÁRMACOS (SISTEMA CARDIOVASCULAR) (APLICAÇÕES TERAPÊUTICAS), ENDOTÉLIO VASCULAR (ENZIMOLOGIA;EFEITOS DE DROGAS), HIPERTENSÃO
ABNT
MONTENEGRO, Marcelo F. et al. Vascular xanthine oxidoreductase contributes to the antihypertensive effects of sodium nitrite in L-NAME hypertension. Naunyn-Schmiedeberg's Archives of Pharmacology, v. 387, n. 6, p. 591-598, 2014Tradução . . Disponível em: https://doi.org/10.1007/s00210-014-0970-8. Acesso em: 01 maio 2024.APA
Montenegro, M. F., Pinheiro, L. C., Amaral, J. H., Ferreira, G. C., Portella, R. L., & Tanus-Santos, J. E. (2014). Vascular xanthine oxidoreductase contributes to the antihypertensive effects of sodium nitrite in L-NAME hypertension. Naunyn-Schmiedeberg's Archives of Pharmacology, 387( 6), 591-598. doi:10.1007/s00210-014-0970-8NLM
Montenegro MF, Pinheiro LC, Amaral JH, Ferreira GC, Portella RL, Tanus-Santos JE. Vascular xanthine oxidoreductase contributes to the antihypertensive effects of sodium nitrite in L-NAME hypertension [Internet]. Naunyn-Schmiedeberg's Archives of Pharmacology. 2014 ; 387( 6): 591-598.[citado 2024 maio 01 ] Available from: https://doi.org/10.1007/s00210-014-0970-8Vancouver
Montenegro MF, Pinheiro LC, Amaral JH, Ferreira GC, Portella RL, Tanus-Santos JE. Vascular xanthine oxidoreductase contributes to the antihypertensive effects of sodium nitrite in L-NAME hypertension [Internet]. Naunyn-Schmiedeberg's Archives of Pharmacology. 2014 ; 387( 6): 591-598.[citado 2024 maio 01 ] Available from: https://doi.org/10.1007/s00210-014-0970-8